195
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Short- and long-term changes in blood miRNA levels after nanogold injection in rats—potential biomarkers of nanoparticle exposure

, , , , &
Pages 750-757 | Received 22 Jul 2011, Accepted 31 Aug 2012, Published online: 03 Oct 2012

References

  • Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, Ong WY. (2010a). Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 31:2034–2042.
  • Balasubramanian SK, Yang L, Yung LY, Ong CN, Ong WY, Yu LE. (2010b). Characterization, purification, and stability of gold nanoparticles. Biomaterials 31:9023–9030.
  • Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297.
  • Boissonneault V, Plante I, Rivest S, Provost P. (2009). MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 284:1971–1981.
  • Brown CL, Bushell G, Whitehouse MW, Agrawal DS, Tupe SG, Paknikar KM, Tiekink ERT. (2007). Nanogold-pharmaceutics: (i) The use of colloidal gold to treat experimentally-induced arthritis in rat models; (ii) Characterization of the gold in Swarna bhasma, a microparticulate used in traditional Indian medicine. Gold Bull 40: 245–250.
  • Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997–1006.
  • Chin LJ, Slack FJ. (2008). A truth serum for cancer–microRNAs have major potential as cancer biomarkers. Cell Res 18:983–984.
  • De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. (2008). Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912–1919.
  • El-Sayed IH, Huang X, El-Sayed MA. (2006). Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 239:129–135.
  • Farraj AK, Hazari MS, Haykal-Coates N, Lamb C, Winsett DW, Ge Y, Ledbetter AD, Carll AP, Bruno M, Ghio A, Costa DL. (2011). ST depression, arrhythmia, vagal dominance, and reduced cardiac micro-RNA in particulate-exposed rats. Am J Respir Cell Mol Biol 44:185–196.
  • Ferrari M. (2005). Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161–171.
  • Griffiths-Jones S. (2006). miRBase: the microRNA sequence database. Methods Mol Biol 342:129–138.
  • Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. (2008). miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154–D158.
  • Gwinn MR, Vallyathan V. (2006). Nanoparticles: health effects–pros and cons. Environ Health Perspect 114:1818–1825.
  • Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schäffler M, Takenaka S, Möller W, Schmid G, Simon U, Kreyling WG. (2011). Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 77:407–416.
  • Hoet PH, Brüske-Hohlfeld I, Salata OV. (2004). Nanoparticles - known and unknown health risks. J Nanobiotechnology 2:12.
  • Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. (2009). Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23:806–812.
  • Jardim MJ, Fry RC, Jaspers I, Dailey L, Diaz-Sanchez D. (2009). Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ Health Perspect 117:1745–1751.
  • Katz E, Willner I. (2004). Integrated nanoparticle-biomolecule hybrid systems: synthesis, properties, and applications. Angew Chem Int Ed Engl 43:6042–6108.
  • Lee RC, Feinbaum RL, Ambros V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854.
  • Lipka J, Semmler-Behnke M, Sperling RA, Wenk A, Takenaka S, Schleh C, Kissel T, Parak WJ, Kreyling WG. (2010). Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31:6574–6581.
  • Liu DZ, Tian Y, Ander BP, Xu H, Stamova BS, Zhan X, Turner RJ, Jickling G, Sharp FR. (2010). Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 30:92–101.
  • Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408.
  • Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513–10518.
  • Pillai RS. (2005). MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11:1753–1761.
  • Provost P. (2010). Interpretation and applicability of microRNA data to the context of Alzheimer’s and age-related diseases. Aging (Albany NY) 2:166–169.
  • Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, Schmid G, Brandau W. (2008). Biodistribution of 1.4- and 18-nm gold particles in rats. Small 4:2108–2111.
  • Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, Wang CW, Jeyaseelan K. (2009). Expression profile of MicroRNAs in young stroke patients. PLoS ONE 4:e7689.
  • Vassar R, Kovacs DM, Yan R, Wong PC. (2009). The beta-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential. J Neurosci 29:12787–12794.
  • Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q. (2010). Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31:659–666.
  • Wang X. (2008). miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14:1012–1017.
  • Wittmann J, Jäck HM. (2010). Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 1806:200–207.
  • Yu LE, Yung LY, Ong CN, Tan YL, Balasubramanian SK, Hartono D. (2007). Translocation and effects of gold nanoparticles after inhalation exposure in rats. Nanotoxicology 1: 235–242.
  • Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J, Mayr M. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810–817.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.